Table 1. Regulatory T Cell Tregs Therapies Consumption Value & CAGR: China VS Global, 2019-2030, US$ Million

Table 2. Regulatory T Cell Tregs Therapies Market Restraints

Table 3. Regulatory T Cell Tregs Therapies Market Trends

Table 4. Regulatory T Cell Tregs Therapies Industry Policy

Table 5. Global Regulatory T Cell Tregs Therapies Revenue by Company, 2019-2024, US$ million, Ranked Based on Revenue in 2022

Table 6. Global Regulatory T Cell Tregs Therapies Revenue Share by Company, 2019-2024, Ranked by Data of 2022

Table 7. Global Regulatory T Cell Tregs Therapies Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 8. Global Regulatory T Cell Tregs Therapies Mergers & Acquisitions, Expansion Plans

Table 9. Global Regulatory T Cell Tregs Therapies Major Companies Product Type

Table 10. Head Office and Area Served of Key Players

Table 11. China Regulatory T Cell Tregs Therapies Revenue by Company, 2019-2024, US$ million, Ranked Based on Revenue in 2022

Table 12. China Regulatory T Cell Tregs Therapies Revenue Market Share by Company, 2019-2024

Table 13. Global Key Players of Regulatory T Cell Tregs Therapies Upstream (Raw Materials)

Table 14. Global Regulatory T Cell Tregs Therapies Typical Customers

Table 15. Regulatory T Cell Tregs Therapies Typical Distributors

Table 16. By Type, Global Regulatory T Cell Tregs Therapies Consumption Value & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 17. By Application, Global Regulatory T Cell Tregs Therapies Consumption Value & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 18. By Region, Global Regulatory T Cell Tregs Therapies Consumption Value, 2019 VS 2024 VS 2030, US$ Million

Table 19. By Region, Global Regulatory T Cell Tregs Therapies Consumption Value, 2019-2030, US$ Million

Table 20. By Country, Global Regulatory T Cell Tregs Therapies Consumption Value & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 21. By Country, Global Regulatory T Cell Tregs Therapies Consumption Value, 2019-2030, US$ Million

Table 22. By Country, Global Regulatory T Cell Tregs Therapies Consumption Value Market Share, 2019-2030

Table 23. Abata Therapeutics Company Information, Head Office, Market Area and Industry Position

Table 24. Abata Therapeutics Company Profile and Main Business

Table 25. Abata Therapeutics Regulatory T Cell Tregs Therapies Models, Specifications, and Application

Table 26. Abata Therapeutics Regulatory T Cell Tregs Therapies Revenue and Gross Margin, US$ Million, 2019-2024

Table 27. Abata Therapeutics Recent Developments

Table 28. Cellenkos Inc Company Information, Head Office, Market Area and Industry Position

Table 29. Cellenkos Inc Company Profile and Main Business

Table 30. Cellenkos Inc Regulatory T Cell Tregs Therapies Models, Specifications, and Application

Table 31. Cellenkos Inc Regulatory T Cell Tregs Therapies Revenue and Gross Margin, US$ Million, 2019-2024

Table 32. Cellenkos Inc Recent Developments

Table 33. Coya Therapeutics Company Information, Head Office, Market Area and Industry Position

Table 34. Coya Therapeutics Company Profile and Main Business

Table 35. Coya Therapeutics Regulatory T Cell Tregs Therapies Models, Specifications, and Application

Table 36. Coya Therapeutics Regulatory T Cell Tregs Therapies Revenue and Gross Margin, US$ Million, 2019-2024

Table 37. Coya Therapeutics Recent Developments

Table 38. Roche Company Information, Head Office, Market Area and Industry Position

Table 39. Roche Company Profile and Main Business

Table 40. Roche Regulatory T Cell Tregs Therapies Models, Specifications, and Application

Table 41. Roche Regulatory T Cell Tregs Therapies Revenue and Gross Margin, US$ Million, 2019-2024

Table 42. Roche Recent Developments

Table 43. Caladrius Biosciences Company Information, Head Office, Market Area and Industry Position

Table 44. Caladrius Biosciences Company Profile and Main Business

Table 45. Caladrius Biosciences Regulatory T Cell Tregs Therapies Models, Specifications, and Application

Table 46. Caladrius Biosciences Regulatory T Cell Tregs Therapies Revenue and Gross Margin, US$ Million, 2019-2024

Table 47. Caladrius Biosciences Recent Developments

Table 48. Sonoma Biotherapeutics Company Information, Head Office, Market Area and Industry Position

Table 49. Sonoma Biotherapeutics Company Profile and Main Business

Table 50. Sonoma Biotherapeutics Regulatory T Cell Tregs Therapies Models, Specifications, and Application

Table 51. Sonoma Biotherapeutics Regulatory T Cell Tregs Therapies Revenue and Gross Margin, US$ Million, 2019-2024

Table 52. Sonoma Biotherapeutics Recent Developments

Table 53. Nektar Therapeutics Company Information, Head Office, Market Area and Industry Position

Table 54. Nektar Therapeutics Company Profile and Main Business

Table 55. Nektar Therapeutics Regulatory T Cell Tregs Therapies Models, Specifications, and Application

Table 56. Nektar Therapeutics Regulatory T Cell Tregs Therapies Revenue and Gross Margin, US$ Million, 2019-2024

Table 57. Nektar Therapeutics Recent Developments

Table 58. Eli Lilly And Company Company Information, Head Office, Market Area and Industry Position

Table 59. Eli Lilly And Company Company Profile and Main Business

Table 60. Eli Lilly And Company Regulatory T Cell Tregs Therapies Models, Specifications, and Application

Table 61. Eli Lilly And Company Regulatory T Cell Tregs Therapies Revenue and Gross Margin, US$ Million, 2019-2024

Table 62. Eli Lilly And Company Recent Developments

Table 63. Regimmune Company Information, Head Office, Market Area and Industry Position

Table 64. Regimmune Company Profile and Main Business

Table 65. Regimmune Regulatory T Cell Tregs Therapies Models, Specifications, and Application

Table 66. Regimmune Regulatory T Cell Tregs Therapies Revenue and Gross Margin, US$ Million, 2019-2024

Table 67. Regimmune Recent Developments

Table 68. Miltenyi Biotec Company Information, Head Office, Market Area and Industry Position

Table 69. Miltenyi Biotec Company Profile and Main Business

Table 70. Miltenyi Biotec Regulatory T Cell Tregs Therapies Models, Specifications, and Application

Table 71. Miltenyi Biotec Regulatory T Cell Tregs Therapies Revenue and Gross Margin, US$ Million, 2019-2024

Table 72. Miltenyi Biotec Recent Developments

Table 73. Teraimmune Company Information, Head Office, Market Area and Industry Position

Table 74. Teraimmune Company Profile and Main Business

Table 75. Teraimmune Regulatory T Cell Tregs Therapies Models, Specifications, and Application

Table 76. Teraimmune Regulatory T Cell Tregs Therapies Revenue and Gross Margin, US$ Million, 2019-2024

Table 77. Teraimmune Recent Developments

Table 78. Tract Therapeutics Company Information, Head Office, Market Area and Industry Position

Table 79. Tract Therapeutics Company Profile and Main Business

Table 80. Tract Therapeutics Regulatory T Cell Tregs Therapies Models, Specifications, and Application

Table 81. Tract Therapeutics Regulatory T Cell Tregs Therapies Revenue and Gross Margin, US$ Million, 2019-2024

Table 82. Tract Therapeutics Recent Developments

Table 83. Vt Bio Company Information, Head Office, Market Area and Industry Position

Table 84. Vt Bio Company Profile and Main Business

Table 85. Vt Bio Regulatory T Cell Tregs Therapies Models, Specifications, and Application

Table 86. Vt Bio Regulatory T Cell Tregs Therapies Revenue and Gross Margin, US$ Million, 2019-2024

Table 87. Vt Bio Recent Developments

Table 88. Amgen Company Information, Head Office, Market Area and Industry Position

Table 89. Amgen Company Profile and Main Business

Table 90. Amgen Regulatory T Cell Tregs Therapies Models, Specifications, and Application

Table 91. Amgen Regulatory T Cell Tregs Therapies Revenue and Gross Margin, US$ Million, 2019-2024

Table 92. Amgen Recent Developments

Table 93. Sangamo Therapeutics (Txcell) Company Information, Head Office, Market Area and Industry Position

Table 94. Sangamo Therapeutics (Txcell) Company Profile and Main Business

Table 95. Sangamo Therapeutics (Txcell) Regulatory T Cell Tregs Therapies Models, Specifications, and Application

Table 96. Sangamo Therapeutics (Txcell) Regulatory T Cell Tregs Therapies Revenue and Gross Margin, US$ Million, 2019-2024

Table 97. Sangamo Therapeutics (Txcell) Recent Developments

Table 98. Pfizer Inc Company Information, Head Office, Market Area and Industry Position

Table 99. Pfizer Inc Company Profile and Main Business

Table 100. Pfizer Inc Regulatory T Cell Tregs Therapies Models, Specifications, and Application

Table 101. Pfizer Inc Regulatory T Cell Tregs Therapies Revenue and Gross Margin, US$ Million, 2019-2024

Table 102. Pfizer Inc Recent Developments

Table 103. Poltreg Sa Company Information, Head Office, Market Area and Industry Position

Table 104. Poltreg Sa Company Profile and Main Business

Table 105. Poltreg Sa Regulatory T Cell Tregs Therapies Models, Specifications, and Application

Table 106. Poltreg Sa Regulatory T Cell Tregs Therapies Revenue and Gross Margin, US$ Million, 2019-2024

Table 107. Poltreg Sa Recent Developments

Table 108. Parvus Therapeutics Company Information, Head Office, Market Area and Industry Position

Table 109. Parvus Therapeutics Company Profile and Main Business

Table 110. Parvus Therapeutics Regulatory T Cell Tregs Therapies Models, Specifications, and Application

Table 111. Parvus Therapeutics Regulatory T Cell Tregs Therapies Revenue and Gross Margin, US$ Million, 2019-2024

Table 112. Parvus Therapeutics Recent Developments

Table 113. Celgene Company Information, Head Office, Market Area and Industry Position

Table 114. Celgene Company Profile and Main Business

Table 115. Celgene Regulatory T Cell Tregs Therapies Models, Specifications, and Application

Table 116. Celgene Regulatory T Cell Tregs Therapies Revenue and Gross Margin, US$ Million, 2019-2024

Table 117. Celgene Recent Developments

List of Figures

Figure 1. Regulatory T Cell Tregs Therapies Picture

Figure 2. Global Regulatory T Cell Tregs Therapies Consumption Value, (US$ million) & (2019-2030)

Figure 3. China Regulatory T Cell Tregs Therapies Consumption Value, (US$ million) & (2019-2030)

Figure 4. By Consumption Value, China Regulatory T Cell Tregs Therapies Market Share of Global, 2019-2030

Figure 5. Global Regulatory T Cell Tregs Therapies Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022

Figure 6. China Regulatory T Cell Tregs Therapies Key Participants, Market Share, 2022

Figure 7. Regulatory T Cell Tregs Therapies Industry Chain

Figure 8. Regulatory T Cell Tregs Therapies Procurement Model

Figure 9. Regulatory T Cell Tregs Therapies Sales Model

Figure 10. Regulatory T Cell Tregs Therapies Sales Channels, Direct Sales, and Distribution

Figure 11. Tregs

Figure 12. Interleukin 2

Figure 13. Monoclonal Antibodies

Figure 14. Others

Figure 15. By Type, Global Regulatory T Cell Tregs Therapies Consumption Value, 2019-2030, US$ Million

Figure 16. By Type, Global Regulatory T Cell Tregs Therapies Consumption Value Market Share, 2019-2030

Figure 17. Hospital

Figure 18. Clinic

Figure 19. Others

Figure 20. By Application, Global Regulatory T Cell Tregs Therapies Consumption Value, 2019-2030, US$ Million

Figure 21. By Application, Global Regulatory T Cell Tregs Therapies Consumption Value Market Share, 2019-2030

Figure 22. By Region, Global Regulatory T Cell Tregs Therapies Consumption Value Market Share, 2019-2030

Figure 23. North America Regulatory T Cell Tregs Therapies Consumption Value & Forecasts, 2019-2030, US$ Million

Figure 24. By Country, North America Regulatory T Cell Tregs Therapies Consumption Value Market Share, 2022

Figure 25. Europe Regulatory T Cell Tregs Therapies Consumption Value & Forecasts, 2019-2030, US$ Million

Figure 26. By Country, Europe Regulatory T Cell Tregs Therapies Consumption Value Market Share, 2022

Figure 27. Asia Pacific Regulatory T Cell Tregs Therapies Consumption Value & Forecasts, 2019-2030, US$ Million

Figure 28. By Country/Region, Asia Pacific Regulatory T Cell Tregs Therapies Consumption Value Market Share, 2022

Figure 29. South America Regulatory T Cell Tregs Therapies Consumption Value & Forecasts, 2019-2030, US$ Million

Figure 30. By Country, South America Regulatory T Cell Tregs Therapies Consumption Value Market Share, 2022

Figure 31. Middle East & Africa Regulatory T Cell Tregs Therapies Consumption Value & Forecasts, 2019-2030, US$ Million

Figure 32. U.S. Regulatory T Cell Tregs Therapies Consumption Value, 2019-2030, US$ Million

Figure 33. By Type, U.S. Regulatory T Cell Tregs Therapies Consumption Value Market Share, 2022 VS 2029

Figure 34. By Application, U.S. Regulatory T Cell Tregs Therapies Consumption Value Market Share, 2022 VS 2029

Figure 35. Europe Regulatory T Cell Tregs Therapies Consumption Value, 2019-2030, US$ Million

Figure 36. By Type, Europe Regulatory T Cell Tregs Therapies Consumption Value Market Share, 2022 VS 2029

Figure 37. By Application, Europe Regulatory T Cell Tregs Therapies Consumption Value Market Share, 2022 VS 2029

Figure 38. China Regulatory T Cell Tregs Therapies Consumption Value, 2019-2030, US$ Million

Figure 39. By Type, China Regulatory T Cell Tregs Therapies Consumption Value Market Share, 2022 VS 2029

Figure 40. By Application, China Regulatory T Cell Tregs Therapies Consumption Value Market Share, 2022 VS 2029

Figure 41. Japan Regulatory T Cell Tregs Therapies Consumption Value, 2019-2030, US$ Million

Figure 42. By Type, Japan Regulatory T Cell Tregs Therapies Consumption Value Market Share, 2022 VS 2029

Figure 43. By Application, Japan Regulatory T Cell Tregs Therapies Consumption Value Market Share, 2022 VS 2029

Figure 44. South Korea Regulatory T Cell Tregs Therapies Consumption Value, 2019-2030, US$ Million

Figure 45. By Type, South Korea Regulatory T Cell Tregs Therapies Consumption Value Market Share, 2022 VS 2029

Figure 46. By Application, South Korea Regulatory T Cell Tregs Therapies Consumption Value Market Share, 2022 VS 2029

Figure 47. Southeast Asia Regulatory T Cell Tregs Therapies Consumption Value, 2019-2030, US$ Million

Figure 48. By Type, Southeast Asia Regulatory T Cell Tregs Therapies Consumption Value Market Share, 2022 VS 2029

Figure 49. By Application, Southeast Asia Regulatory T Cell Tregs Therapies Consumption Value Market Share, 2022 VS 2029

Figure 50. India Regulatory T Cell Tregs Therapies Consumption Value, 2019-2030, US$ Million

Figure 51. By Type, India Regulatory T Cell Tregs Therapies Consumption Value Market Share, 2022 VS 2029

Figure 52. By Application, India Regulatory T Cell Tregs Therapies Consumption Value Market Share, 2022 VS 2029

Figure 53. Middle East & Africa Regulatory T Cell Tregs Therapies Consumption Value, 2019-2030, US$ Million

Figure 54. By Type, Middle East & Africa Regulatory T Cell Tregs Therapies Consumption Value Market Share, 2022 VS 2029

Figure 55. By Application, Middle East & Africa Regulatory T Cell Tregs Therapies Consumption Value Market Share, 2022 VS 2029

Figure 56. Research Methodology

Figure 57. Breakdown of Primary Interviews

Figure 58. Bottom-up and Top-down Approaches

Figure 59. Top-down Approaches